UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 9, 2004 CardioDynamics International Corporation (Exact name of registrant as specified in its charter) California 0-11868 95-3533362 ________________________________________________________________________________ (State or other jurisdiction (Commission (I.R.S. Employer of incorporation) File Number) Identification No.) 6175 Nancy Ridge Drive, San Diego, California 92121 ________________________________________________________________________________ (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (858) 535-0202 _______________ n/a ________________________________________________________________________________ (Former name or former address, if changed since last report) Items 5. Other Events: Exhibit filed with this report: Exhibit 1.1 Registrant's press release dated February 9, 2004, publicly announcing the Strategic Alliance with MDS Pharma Services. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CARDIODYNAMICS INTERNATIONAL CORPORATION Date: February 9, 2004 By: /s/ Stephen P. Loomis _____________________ Stephen P. Loomis Chief Financial Officer